These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16920102)

  • 41. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
    Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
    Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrophysiological effects of neurotensin on globus pallidus neurons of 6-hydroxydopamine-lesioned rats.
    Xue Y; Bai B; Yung WH; Chen L
    Neurosignals; 2009; 17(2):153-61. PubMed ID: 19202346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The basal ganglia circuits, dopamine, and ambiguous word processing: a neurobiological account of priming studies in Parkinson's disease.
    Chenery HJ; Angwin AJ; Copland DA
    J Int Neuropsychol Soc; 2008 May; 14(3):351-64. PubMed ID: 18419834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subthalamic nucleus neuronal activity in Parkinson's disease and epilepsy subjects.
    Montgomery EB
    Parkinsonism Relat Disord; 2008; 14(2):120-5. PubMed ID: 17870651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism.
    Fantin M; Auberson YP; Morari M
    J Neurochem; 2008 Jul; 106(2):957-68. PubMed ID: 18435828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide.
    Singh S; Dikshit M
    Brain Res Rev; 2007 Jun; 54(2):233-50. PubMed ID: 17408564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Body mass index in Parkinson's disease.
    Munhoz RP; Ribas CB
    Parkinsonism Relat Disord; 2005 Sep; 11(6):407; author reply 409. PubMed ID: 15893501
    [No Abstract]   [Full Text] [Related]  

  • 48. Re: Management of Parkinson's disease: a review of current and new therapies. Tilak Mendis, Oksana Suchowersky, Anthony Lang, Serge Gauthier. Can J Neurol Sci 1999;26:89-103.
    Bertrand C
    Can J Neurol Sci; 2000 Feb; 27(1):84. PubMed ID: 10676596
    [No Abstract]   [Full Text] [Related]  

  • 49. Cortically evoked responses of human pallidal neurons.
    Montgomery E
    Mov Disord; 2011 Dec; 26(14):2583; author reply 2583-4. PubMed ID: 21994043
    [No Abstract]   [Full Text] [Related]  

  • 50. Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation.
    Rajput AH; Sitte HH; Rajput A; Fenton ME; Pifl C; Hornykiewicz O
    Neurology; 2008 Apr; 70(16 Pt 2):1403-10. PubMed ID: 18172064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease (Silva MF et al. Brain 2005; 128: 2260-2271).
    Gaynes BI
    Brain; 2006 Dec; 129(Pt 12):e61; aauthor reply e62. PubMed ID: 17132640
    [No Abstract]   [Full Text] [Related]  

  • 52. Basal ganglia oscillations and pathophysiology of movement disorders.
    Rivlin-Etzion M; Marmor O; Heimer G; Raz A; Nini A; Bergman H
    Curr Opin Neurobiol; 2006 Dec; 16(6):629-37. PubMed ID: 17084615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nigrofugal connections in the primate brain.
    Mettler FA
    J Comp Neurol; 1970 Mar; 138(3):291-319. PubMed ID: 4986157
    [No Abstract]   [Full Text] [Related]  

  • 54. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
    Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P
    Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of surgery targeting the caudal intralaminar thalamic nuclei on the pathophysiological functioning of basal ganglia in a rat model of Parkinson's disease.
    Kerkerian-Le Goff L; Bacci JJ; Jouve L; Melon C; Salin P
    Brain Res Bull; 2009 Feb; 78(2-3):80-4. PubMed ID: 18790021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathological network activity in Parkinson's disease: from neural activity and connectivity to causality?
    Timmermann L; Fink GR
    Brain; 2011 Feb; 134(Pt 2):332-4. PubMed ID: 21278405
    [No Abstract]   [Full Text] [Related]  

  • 57. Prior pallidotomy reduces and modifies neuronal activity in the subthalamic nucleus of Parkinson's disease patients.
    Zaidel A; Moran A; Marjan G; Bergman H; Israel Z
    Eur J Neurosci; 2008 Jan; 27(2):483-91. PubMed ID: 18215242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new sensitive imaging biomarker for Parkinson disease?
    Lang AE; Mikulis D
    Neurology; 2009 Apr; 72(16):1374-5. PubMed ID: 19129504
    [No Abstract]   [Full Text] [Related]  

  • 59. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
    Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
    Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overview of the extranigral aspects of Parkinson disease.
    Lim SY; Fox SH; Lang AE
    Arch Neurol; 2009 Feb; 66(2):167-72. PubMed ID: 19204152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.